GS Regimen as the First-line Chemotherapy in Chinese Advanced PC Patients

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

January 1, 2014

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions

Pancreatic CancerChemotherapy EffectChemotherapeutic Toxicity

Interventions

DRUG

Gemcitabine plus S-1 (GS) was used to treat advanced pancreatic cancer

Trial Locations (1)

First affiliated hospital, Zhejiang University, Hangzhou

All Listed Sponsors

lead

Zhejiang University

OTHER

NCT03869294 - GS Regimen as the First-line Chemotherapy in Chinese Advanced PC Patients | Biotech Hunter | Biotech Hunter